SR2211 is a potent and selective inverse agonist of the nuclear receptor RORgamma, exhibiting an IC50 of 320 nM and a Ki of 105 nM. This small molecule is a valuable research tool for studying Th17 cell biology, autoimmune diseases, and cancer in both cellular and animal models.